Likewise, the researchers showed that most of the patients with diabetes who were on ambulatory treatment with DPP4 inhibitors had no radiological findings of ARSD, proposing a potential role of DPP4 in COVID‐19.8 The gene discussed is DPP4; the disease is COVID-19.